Effects of Different Combined Bronchodilator Therapies on Airway Inflammation in COPD

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.7, 2005-01, pp. : 453-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of airway inflammation in asthma and COPD

By Caramori G. Adcock I.

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 5, 2003-10 ,pp. : 247-277

Elsevier

Access to resources Recommend Favorite

Cilomilast reduces airway inflammation in COPD

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Targeting Airway Inflammation: Novel Therapies for the Treatment of Asthma

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3105-3111

Bentham Science Publishers

Access to resources Recommend Favorite

New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β₂ agonists in combination or combined into a single molecule

By Norman Peter

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1569-1580

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Current Therapies on Airway Remodeling in Asthma and New Possibilities for Treatment and Prevention

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 169-181

Bentham Science Publishers

Access to resources Recommend Favorite